A total of $343 million in private capital was invested in five key biotechnology/therapeutics initiatives for the week ending January…
Read More »Manager News
It is by now conventional wisdom that the inauguration of Joseph Biden as the new President of the United States…
Read More »
Crosslink Capital announced the close of its ninth venture capital fund, which was oversubscribed with a $350 million fundraise. Crosslink…
Read More »
Point72 Ventures, the independent venture capital arm of hedge fund trader Steven Cohen’s global asset management firm, led a $7…
Read More »
Neuberger Berman launched with $208 million the NB Crossroads Private Markets Access Fund LLC, a closed-end fund that was set…
Read More »
Zurich-based Blue Horizon Ventures closed its inaugural flagship fund, Blue Horizon Ventures I, at €183 million ($222 million), exceeding its…
Read More »
Stephane Chevrier joined BEX Capital, the French private equity secondaries firm, to head North American activities out of a newly…
Read More »
Alternative investment platform Vinci Partners announced the launch of its initial public offering on the Nasdaq Global Select Market, with…
Read More »
Hedge funds, private equity firms, leading sovereign wealth funds and pensions this past week marched into emerging healthcare technologies that…
Read More »
Audax Private Equity completed the fundraise for its first Continuation Fund, which is also its first GP-led secondary private equity…
Read More »